Hepatobiliary Cancers: Progress in Diagnosis, Pathogenesis, and Treatment

Research output: Contribution to journalEditorialpeer-review


Hepatobiliary cancers comprise a wide range of malignancies such as hepatocellular carcinoma and cholangiocarcinoma, and they are some of the most challenging to treat human neoplasms. Due to the rarity of the illnesses, the development of treatment measures for malignancies of the gastrointestinal system is far behind. The number of patients eligible for curative treatment is limited due to cancer's aggressive nature and the difficulties of early identification. Furthermore, surgery is frequently intrusive and linked with a significant level of risk. The therapy result of hepatobiliary cancers is unsatisfactory due to these complicated variables, leaving significant space for improvement.

Original languageEnglish (US)
JournalTechnology in Cancer Research and Treatment
StatePublished - 2022

Bibliographical note

Publisher Copyright:
© The Author(s) 2022.


  • cholangiocarcinoma
  • hepatobilarry cancer
  • hepatocellular carcinoma
  • liver cancer
  • signaling pathway

PubMed: MeSH publication types

  • Editorial


Dive into the research topics of 'Hepatobiliary Cancers: Progress in Diagnosis, Pathogenesis, and Treatment'. Together they form a unique fingerprint.

Cite this